187:
29:
480:
379:
Nakamura M, Shimizu Y, Sato Y, Miyazaki Y, Satoh T, Mizuno M, et al. (August 2007). "Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice".
274:
260:
417:"TAP2, a peptide antagonist of Toll-like receptor 4, attenuates pain and cartilage degradation in a monoiodoacetate-induced arthritis rat model"
521:
294:
44:
540:
126:
560:
166:
514:
545:
155:
507:
428:
321:
182:
61:
550:
456:
397:
302:
InChI=1S/C13H11N3OS/c14-10-3-1-2-4-11(10)17-8-5-6-9-12(7-8)18-16-13(9)15/h1-7H,14H2,(H2,15,16)
115:
491:
446:
436:
389:
329:
203:
70:
186:
135:
555:
432:
451:
416:
534:
95:
487:
337:
393:
349:
441:
28:
354:
236:
106:
333:
460:
401:
479:
415:
Park H, Hong J, Yin Y, Joo Y, Kim Y, Shin J, et al. (October 2020).
359:
325:
81:
20:
146:
259:
250:
320:
is a drug which acts as a potent and selective antagonist of
171:
495:
248:
235:
202:
197:
165:
145:
125:
105:
80:
60:
35:
324:(TLR4). In animal studies it blocks TLR4-mediated
94:
69:
332:effects, showing efficacy in animal models of
515:
8:
19:
52:6-(2-aminophenoxy)-1,2-benzothiazol-3-amine
522:
508:
185:
114:
27:
450:
440:
134:
371:
299:
282:C1=CC=C(C(=C1)N)OC2=CC3=C(C=C2)C(=NS3)N
279:
181:
49:
18:
154:
7:
476:
474:
85:
494:. You can help Knowledge (XXG) by
14:
478:
382:European Journal of Pharmacology
220:
214:
307:Key:HQCTTYOADNAJJR-UHFFFAOYSA-N
229:
226:
208:
1:
394:10.1016/j.ejphar.2007.05.013
577:
473:
442:10.1038/s41598-020-74544-5
198:Chemical and physical data
290:
270:
40:
26:
490:-related article is a
541:Receptor antagonists
322:toll-like receptor 4
433:2020NatSR..1017451P
23:
561:Pharmacology stubs
421:Scientific Reports
503:
502:
315:
314:
261:Interactive image
167:CompTox Dashboard
16:Chemical compound
568:
524:
517:
510:
482:
475:
465:
464:
454:
444:
412:
406:
405:
376:
330:antiinflammatory
328:release and has
263:
243:
231:
228:
222:
216:
210:
190:
189:
175:
173:
158:
138:
118:
98:
88:
87:
73:
31:
24:
22:
576:
575:
571:
570:
569:
567:
566:
565:
531:
530:
529:
528:
471:
469:
468:
414:
413:
409:
378:
377:
373:
368:
346:
311:
308:
303:
298:
297:
286:
283:
278:
277:
266:
241:
225:
219:
213:
193:
183:DTXSID701336699
169:
161:
141:
121:
101:
84:
76:
56:
53:
48:
47:
17:
12:
11:
5:
574:
572:
564:
563:
558:
553:
548:
546:Benzothiazoles
543:
533:
532:
527:
526:
519:
512:
504:
501:
500:
483:
467:
466:
407:
370:
369:
367:
364:
363:
362:
357:
352:
345:
342:
313:
312:
310:
309:
306:
304:
301:
293:
292:
291:
288:
287:
285:
284:
281:
273:
272:
271:
268:
267:
265:
264:
256:
254:
246:
245:
239:
233:
232:
223:
217:
211:
206:
200:
199:
195:
194:
192:
191:
178:
176:
163:
162:
160:
159:
151:
149:
143:
142:
140:
139:
131:
129:
123:
122:
120:
119:
111:
109:
103:
102:
100:
99:
91:
89:
78:
77:
75:
74:
66:
64:
58:
57:
55:
54:
51:
43:
42:
41:
38:
37:
33:
32:
15:
13:
10:
9:
6:
4:
3:
2:
573:
562:
559:
557:
554:
552:
549:
547:
544:
542:
539:
538:
536:
525:
520:
518:
513:
511:
506:
505:
499:
497:
493:
489:
484:
481:
477:
472:
462:
458:
453:
448:
443:
438:
434:
430:
426:
422:
418:
411:
408:
403:
399:
395:
391:
388:(3): 237–43.
387:
383:
375:
372:
365:
361:
358:
356:
353:
351:
348:
347:
343:
341:
339:
335:
331:
327:
323:
319:
305:
300:
296:
289:
280:
276:
269:
262:
258:
257:
255:
252:
247:
240:
238:
234:
207:
205:
201:
196:
188:
184:
180:
179:
177:
168:
164:
157:
153:
152:
150:
148:
144:
137:
133:
132:
130:
128:
124:
117:
113:
112:
110:
108:
104:
97:
93:
92:
90:
83:
79:
72:
68:
67:
65:
63:
59:
50:
46:
39:
34:
30:
25:
496:expanding it
488:pharmacology
485:
470:
427:(1): 17451.
424:
420:
410:
385:
381:
374:
338:septic shock
317:
316:
156:ChEMBL458612
350:TLR4-IN-C34
244: g·mol
71:613262-61-6
36:Identifiers
535:Categories
366:References
355:Resatorvid
249:3D model (
237:Molar mass
136:D98NBX7QJ5
107:ChemSpider
62:CAS Number
45:IUPAC name
334:arthritis
551:Anilines
461:33060735
402:17588563
360:VGX-1027
344:See also
326:cytokine
116:24691458
96:44224215
452:7567100
429:Bibcode
204:Formula
82:PubChem
556:Amines
459:
449:
400:
318:M62812
275:SMILES
242:257.31
147:ChEMBL
21:M62812
486:This
295:InChI
251:JSmol
492:stub
457:PMID
398:PMID
336:and
127:UNII
447:PMC
437:doi
390:doi
386:569
172:EPA
86:CID
537::
455:.
445:.
435:.
425:10
423:.
419:.
396:.
384:.
340:.
218:11
212:13
523:e
516:t
509:v
498:.
463:.
439::
431::
404:.
392::
253:)
230:S
227:O
224:3
221:N
215:H
209:C
174:)
170:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
